Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (89)
  • Open Access

    ARTICLE

    CircUCP2 promotes the tumor progression of non-small cell lung cancer through the miR-149/UCP2 pathway

    WEI DU1, FANG YIN1, YATING ZHONG1, MINJIE LUO1, ZHEN WANG2, PENG LIN2, QING LIU2,*, HAN YANG2,*

    Oncology Research, Vol.31, No.6, pp. 929-936, 2023, DOI:10.32604/or.2023.030611

    Abstract Non-small cell lung cancer (NSCLC) is a highly lethal cancer, and better treatments are urgently needed. Many studies have implicated circular RNAs (circRNAs) in the progression of multiple malignant tumors. Nonetheless, the functions of circRNAs in NSCLC remain unclear. To study new targets for the treatment of NSCLC, circRNA expression profiling was performed on NSCLC tissues and para-carcinoma nonmalignant tissues. RNA was isolated and used for circRNA sequencing. Biological studies were performed in vitro and in vivo to determine the functions of circRNAs in NSCLC, including their functions in cell proliferation and migration. How circRNAs function in NSCLC was explored… More > Graphic Abstract

    CircUCP2 promotes the tumor progression of non-small cell lung cancer through the miR-149/UCP2 pathway

  • Open Access

    ARTICLE

    Changes in intracellular and extracellular proteins after ERGIC3 knockdown in lung cancer: Proteins interacting with ERGIC3, HORN, and FLNA

    WEI ZHAI1,2, XIANG ZHENG2, MENGYUAN LIU2, QIURONG ZHAO2, YUSHU ZHANG2, YUQING LUO3, SHANSHAN FENG3, JINJING WANG3, XUEYING LI2,*, MINGSONG WU1,*

    BIOCELL, Vol.47, No.8, pp. 1821-1833, 2023, DOI:10.32604/biocell.2023.027175

    Abstract Objective: Endoplasmic reticulum-Golgi intermediate compartment 3 (ERGIC3) promotes cell proliferation and metastasis in lung cancer, but its molecular mechanism is unclear. Methods: The GLC-82 cells were randomly divided into the ERGIC3i group and the negative control group. The cells were transfected with ERGIC3 siRNA or control siRNA in the groups, respectively. The ERGIC3-interacting proteins expressed in cells or extracellularly were isolated by the immunoprecipitation method and detected by isobaric tags for relative and absolute quantitation and liquid chromatography-tandem mass spectrometry. The differentially expressed proteins were determined by bioinformatic methods. Results: After ERGIC3 knockdown, 88 extracellular differentially expressed proteins, 41 up-regulated… More >

  • Open Access

    ARTICLE

    Deep Belief Network for Lung Nodule Segmentation and Cancer Detection

    Sindhuja Manickavasagam*, Poonkuzhali Sugumaran

    Computer Systems Science and Engineering, Vol.47, No.1, pp. 135-151, 2023, DOI:10.32604/csse.2023.030344

    Abstract Cancer disease is a deadliest disease cause more dangerous one. By identifying the disease through Artificial intelligence to getting the mage features directly from patients. This paper presents the lung knob division and disease characterization by proposing an enhancement calculation. Most of the machine learning techniques failed to observe the feature dimensions leads inaccuracy in feature selection and classification. This cause inaccuracy in sensitivity and specificity rate to reduce the identification accuracy. To resolve this problem, to propose a Chicken Sine Cosine Algorithm based Deep Belief Network to identify the disease factor. The general technique of the created approach includes… More >

  • Open Access

    ARTICLE

    High expression of PD-L1 mainly occurs in non-small cell lung cancer patients with squamous cell carcinoma or poor differentiation

    LU LIU1,2, BIN XIE1,2, WEI ZHU1,2, QIUYAN HE1,2, JIANHUA ZHOU1,2, SHUANG LIU3, YONGGUANG TAO4, DESHENG XIAO1,2,*

    Oncology Research, Vol.31, No.3, pp. 275-286, 2023, DOI:10.32604/or.2023.028227

    Abstract Background: Lung cancer is one of the most lethal cancers worldwide, but studies have shown that the higher the expression of programmed cell death protein 1 ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC), the more likely it will benefit from anti-PD-L1 immunotherapy. The purpose of our study was to collect and analyze abundant clinical samples in order to provide evidence for clinicians and patients who might consider anti-PD-L1 immunotherapy while jointly formulating treatment plans. Methods: On the one hand, we obtained cases from The Cancer Genome Atlas (TCGA) database, including 498 lung squamous cell cancer (LUSC) patients and… More >

  • Open Access

    VIEWPOINT

    Analysis of tumor-draining vein secretome: A direct access to tumor-derived extracellular vesicles in surgical lung cancer patients

    YANGYI HE1,2, DAVID SANCHEZ-LORENTE3,4,5, MELISSA ACOSTA-PLASENCIA1, MARC BOADA3,4,5, ANGELA GUIRAO3,4,5, RAMON M. MARRADES4,5,6,7, LAUREANO MOLINS3,4,5, ALFONS NAVARRO1,4,5,*

    BIOCELL, Vol.47, No.5, pp. 951-957, 2023, DOI:10.32604/biocell.2023.027718

    Abstract Tumor-secreted extracellular vesicles (EVs) participate in the metastasis process through different mechanisms, including the preparation of the pre-metastatic niche to grant circulating tumor cells (CTCs) implantation and growth. The study of the metastasis process through the analysis of CTCs and tumor-derived EVs is difficult because of the dilution grade of these elements in peripheral blood. In early-stage lung cancer patients, the tumor-secreted products are even more diluted. An attractive strategy in surgical lung cancer patients is to purify them from a pulmonary tumor-draining vein where they are enriched. The information obtained from the analysis of EVs and CTCs purified from… More >

  • Open Access

    ARTICLE

    Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells

    SANDRA STICKLER1, BARBARA RATH1, MAXIMILIAN HOCHMAIR2, CLEMENS LANG3, LUKAS WEIGL4, GERHARD HAMILTON1,*

    Oncology Research, Vol.31, No.1, pp. 13-22, 2023, DOI:10.32604/or.2022.027281

    Abstract Small cell lung cancer (SCLC) is frequently disseminated and has a dismal prognosis with survival times of approximately two years. This cancer responds well to initial chemotherapy but recurs within a short time as a globally chemoresistant tumor. Circulating tumor cells (CTCs) are held responsible for metastasis, the extremely high numbers of these cells in advanced SCLC allowed us to establish several permanent CTC cell lines. These CTCs are distinguished by the spontaneous formation of large spheroids, termed tumorospheres, in regular tissue culture. These contain quiescent and hypoxic cells in their interior and are associated with high chemoresistance compared to… More >

  • Open Access

    ARTICLE

    Lung Cancer Segmentation with Three-Parameter Logistic Type Distribution Model

    Debnath Bhattacharyya1, Eali. Stephen Neal Joshua2, N. Thirupathi Rao2, Yung-cheol Byun3,*

    CMC-Computers, Materials & Continua, Vol.75, No.1, pp. 1447-1465, 2023, DOI:10.32604/cmc.2023.031878

    Abstract Lung cancer is the leading cause of mortality in the world affecting both men and women equally. When a radiologist just focuses on the patient’s body, it increases the amount of strain on the radiologist and the likelihood of missing pathological information such as abnormalities are increased. One of the primary objectives of this research work is to develop computer-assisted diagnosis and detection of lung cancer. It also intends to make it easier for radiologists to identify and diagnose lung cancer accurately. The proposed strategy which was based on a unique image feature, took into consideration the spatial interaction of… More >

  • Open Access

    ARTICLE

    Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany

    DIEGO HERNANDEZ1,*, CHIH-YUAN CHENG1,2, KARLA HERNANDEZ-VILLAFUERTE1, MICHAEL SCHLANDER1,2

    Oncology Research, Vol.30, No.4, pp. 173-185, 2022, DOI:10.32604/or.2022.027262

    Abstract Lung cancer is the most common cancer type worldwide and has the highest and second highest mortality rate for men and women respectively in Germany. Yet, the role of comorbid illnesses in lung cancer patient prognosis is still debated. We analyzed administrative claims data from one of the largest statutory health insurance (SHI) funds in Germany, covering close to 9 million people (11% of the national population); observation period was from 2005 to 2019. Lung cancer patients and their concomitant diseases were identified by ICD-10-GM codes. Comorbidities were classified according to the Charlson Comorbidity Index (CCI). Incidence, comorbidity prevalence and… More >

  • Open Access

    ARTICLE

    An Intelligent Decision Support System for Lung Cancer Diagnosis

    Ahmed A. Alsheikhy1,*, Yahia F. Said1, Tawfeeq Shawly2

    Computer Systems Science and Engineering, Vol.46, No.1, pp. 799-817, 2023, DOI:10.32604/csse.2023.035269

    Abstract Lung cancer is the leading cause of cancer-related death around the globe. The treatment and survival rates among lung cancer patients are significantly impacted by early diagnosis. Most diagnostic techniques can identify and classify only one type of lung cancer. It is crucial to close this gap with a system that detects all lung cancer types. This paper proposes an intelligent decision support system for this purpose. This system aims to support the quick and early detection and classification of all lung cancer types and subtypes to improve treatment and save lives. Its algorithm uses a Convolutional Neural Network (CNN)… More >

  • Open Access

    ARTICLE

    The synergistic effects of PRDX5 and Nrf2 on lung cancer progression and drug resistance under oxidative stress in the zebrafish models

    SITONG QIAN1,2,#, YING FANG1,#, CHENGYUN YAO1,#, YONGSHENG WANG3,#, ZHI ZHANG1, XIAOHUA WANG1, JIN GAO1, YONG FENG1, LEI SUN1, RUNYUE ZOU2, GUOREN ZHOU1,*, JINJUN YE1,*, RUIXUE XIA4,*, HONGPING XIA5,6,*

    Oncology Research, Vol.30, No.2, pp. 53-64, 2022, DOI:10.32604/or.2022.026302

    Abstract Previous studies have shown that PRDX5 and Nrf2 are antioxidant proteins related to abnormal reactive oxidative species (ROS). PRDX5 and Nrf2 play a critical role in the progression of inflammations and tumors. The combination of PRDX5 and Nrf2 was examined by Co-immunoprecipitation, western blotting and Immunohistochemistry. H2O2 was applied to affect the production of ROS and induced multi-resistant protein 1 (MRP1) expression in NSCLC cells. The zebrafish models mainly investigated the synergistic effects of PRDX5 and Nrf2 on lung cancer drug resistance under oxidative stress. We showed that PRDX5 and Nrf2 form a complex and significantly increase the NSCLC tissues… More >

Displaying 11-20 on page 2 of 89. Per Page